AIMT - Aimmune Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Aimmune Therapeutics's activity chart (see below) currently has 121 price targets and 100 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 35.39% with an average time for these price targets to be met of 119.43 days.

Most recent stock forecast was given by from WELLS FARGO on 01-Sep-2020. First documented stock forecast 31-Aug-2015.

Best performing analysts who are covering AIMT - Aimmune Therapeutics:

Charles Duncan Vamil Divan Paul Choi Evan Seigerman Derek Archila

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 19-Dec-2019

$18

6 years 1 months 7 days ago
(01-Sep-2020)

3/3 (100%)

$3.19 (21.54%)

78

Buy Since 17-Nov-2015

$35

$0.51 (1.48%)

6 years 1 months 7 days ago
(31-Aug-2020)

5/14 (35.71%)

$0.78 (2.28%)

488

Hold Since 04-Feb-2020

$34.5

$0.01 (0.03%)

6 years 1 months 7 days ago
(31-Aug-2020)

5/5 (100%)

$0.28 (0.82%)

138

Buy Since 14-Jun-2016

$34.5

$0.01 (0.03%)

$66

6 years 1 months 7 days ago
(31-Aug-2020)

1/9 (11.11%)

$0.28 (0.82%)

39

Buy Since 03-Jun-2019

$60

6 years 1 months 7 days ago
(31-Aug-2020)

0/19 (0%)

$41.31 (221.03%)

Show more analysts

Please expand the browser size to see the chart

What is AIMT (Aimmune Therapeutics) average time for price targets to be met?

On average it took 119 days for the stock forecasts to be reached, with an average price target met ratio of 35.39%.

Which analyst most recently updated their price target on AIMT (Aimmune Therapeutics)?

Which analyst has the most public recommendations on AIMT (Aimmune Therapeutics)?

has 0 price targets and 0 ratings on AIMT

Which analyst is the currently most bullish on AIMT (Aimmune Therapeutics)?

Jotin Marango with the highest potential upside of $45.51

Which analyst is the currently most reserved on AIMT (Aimmune Therapeutics)?

Andrew Fein with the lowest potential downside of -$19.49
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?